Dezhan Healthcare 관리

관리 기준 확인 2/4

We currently do not have sufficient information about the CEO.

주요 정보

Wei Liu

최고 경영자

CN¥4.0m

총 보상

CEO 급여 비율	n/a
CEO 임기	8.1yrs
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3.3yrs

최근 관리 업데이트

Recent updates

Dezhan Healthcare Company Limited's (SZSE:000813) Share Price Could Signal Some Risk

Oct 25

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Apr 18

CEO

Wei Liu (54 yo)

8.1yrs

테뉴어

CN¥3,980,000

보상

Mr. Wei Liu is Co-Chairman & GM of Dezhan Healthcare Company Limited from October 28, 2016.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Wei Liu	Co-Chairman & GM	8.1yrs	CN¥3.98m	데이터 없음
Weihong Sun	Independent Director	3.3yrs	CN¥180.00k	데이터 없음
Bin Wu	Independent Director	3.3yrs	CN¥180.00k	데이터 없음
Hailin Yan	Non-Independent Director	3.3yrs	데이터 없음	데이터 없음
Zheming Wei	Chairman	8.1yrs	데이터 없음	0.021% CN¥ 1.3m
Feng Han	Director	2.5yrs	데이터 없음	데이터 없음
Sinian Chou	Non-Independent Director	3.3yrs	CN¥60.00k	데이터 없음
Xin An Wang	Independent Director	3.3yrs	CN¥180.00k	데이터 없음
Ping Liu	Supervisor	less than a year	데이터 없음	데이터 없음

3.3yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: 000813's board of directors are considered experienced (3.3 years average tenure).

Dezhan Healthcare 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: CN¥0.001 loss per share (vs CN¥0.021 profit in 3Q 2023)

Dezhan Healthcare Company Limited's (SZSE:000813) Share Price Could Signal Some Risk

Dezhan Healthcare Company Limited to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 24%

Dezhan Healthcare Company Limited (SZSE:000813) announces an Equity Buyback for CNY 300 million worth of its shares.

Second quarter 2024 earnings released: EPS: CN¥0.012 (vs CN¥0.004 loss in 2Q 2023)

Dezhan Healthcare Company Limited to Report First Half, 2024 Results on Aug 28, 2024

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Full year 2023 earnings released: EPS: CN¥0.038 (vs CN¥0.021 loss in FY 2022)

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

Dezhan Healthcare Company Limited to Report Q1, 2024 Results on Apr 25, 2024

Dezhan Healthcare Company Limited to Report Fiscal Year 2023 Results on Apr 12, 2024

Third quarter 2023 earnings released: EPS: CN¥0.033 (vs CN¥0 in 3Q 2022)

Dezhan Healthcare Company Limited to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.016 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.014 in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0 (vs CN¥0.01 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.016 (vs CN¥0.017 in 2Q 2021)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.01 (vs CN¥0.026 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.017 (vs CN¥0.041 in 2Q 2020)

Dezhan Healthcare Company Limited Approves Final Dividend Implementation Plan (A Shares) for 2020, Payable on June 1, 2021

Dezhan Healthcare Company Limited Announces the Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.041 in 1Q 2020)

Investor sentiment improved over the past week

New 90-day low: CN¥3.98

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.85

Dezhan Healthcare's Controlling Shareholder Plans to Sell Stake in the Company

New 90-day high: CN¥6.85

Third quarter earnings released

New 90-day low: CN¥6.05

First half earnings released

Dezhan Healthcare Company Limited to Report First Half, 2020 Results on Aug 29, 2020

Dezhan Healthcare Company Limited (SZSE:000813) completed the acquisition of 70% stake in Beijing Changjiang Mai Medical Technology Co., Ltd from Dai Yanzhen.

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령